Abstract
It is now believed that most epithelial tumors are maintained by a subpopulation of cells called cancer stem cells (CSCs) or tumor initiating cells (TICs) with stem cell-like properties, including self-renewal and multilineage differentiation capacity. Recently new insights into this population have emerged in certain epithelial tumor types, including their Claudinlow phenotype and its importance to the epithelial-mesenchymal transition (EMT) process. Taken together, CSCs, EMT and Claudins appear to constitute an axis-of-evil in cancer, for which better understanding may lead to new therapeutic platforms.
Similar content being viewed by others
References
Sloma, I., Jiang, X., Eaves, A. C., & Eaves, C. J. (2010). Leukemia, 24, 1823–1833.
Maund, S. L. & Cramer, S. D. (2010). Stem Cell Rev.
Lathia, J. D., Venere, M., Rao, M. S., & Rich, J. N. (2010). Stem Cell Rev.
Regenbrecht, C. R., Lehrach, H., & Adjaye, J. (2008). Stem Cell Reviews, 4, 319–328.
Cobaleda, C., Cruz, J. J., Gonzalez-Sarmiento, R., Sanchez-Garcia, I., & Perez-Losada, J. (2008). Stem Cell Reviews, 4, 67–79.
McDermott, S. P., & Wicha, M. S. (2010). Mol Oncol, 4, 404–419.
Iwase, H., Kurebayashi, J., Tsuda, H., Ohta, T., Kurosumi, M., Miyamoto, K., et al. (2010). Breast Cancer, 17, 118–124.
Yamamoto, Y., Ibusuki, M., Nakano, M., Kawasoe, T., Hiki, R., & Iwase, H. (2009). Breast Cancer, 16, 260–267.
Carotenuto, P., Roma, C., Rachiglio, A. M., Botti, G., D’Alessio, A., & Normanno, N. (2010). Critical Reviews in Eukaryotic Gene Expression, 20, 17–34.
Perou, C. M. (2011). The Oncologist, 16(Suppl 1), 61–70.
Furuse, M., Sasaki, H., Fujimoto, K., & Tsukita, S. (1998). The Journal of Cell Biology, 143, 391–401.
Turksen, K., & Troy, T. C. (2001). Developmental Dynamics, 222, 292–300.
Mineta, K., Yamamoto, Y., Yamazaki, Y., Tanaka, H., Tada, Y., Saito, K., et al. (2011). FEBS Letters, 585, 606–612.
Turksen, K., & Troy, T. C. (2004). Journal of Cell Science, 117, 2435–2447.
Turksen, K., & Troy, T. C. (2002). Development, 129, 1775–1784.
Krause, G., Winkler, L., Mueller, S. L., Haseloff, R. F., Piontek, J., & Blasig, I. E. (2008). Biochimica et Biophysica Acta, 1778, 631–645.
Morin, P. J. (2005). Cancer Research, 65, 9603–9606.
Lanigan, F., McKiernan, E., Brennan, D. J., Hegarty, S., Millikan, R. C., McBryan, J., et al. (2009). International Journal of Cancer, 124, 2088–2097.
Hewitt, K. J., Agarwal, R., & Morin, P. J. (2006). BMC Cancer, 6, 186.
Blackman, B., Russell, T., Nordeen, S. K., Medina, D., & Neville, M. C. (2005). Breast Cancer Research, 7, R248–R255.
Taube, J. H., Herschkowitz, J. I., Komurov, K., Zhou, A. Y., Gupta, S., Yang, J., et al. (2010). Proceedings of the National Academy of Sciences of the United States of America, 107, 15449–15454.
Prat, A., Parker, J. S., Karginova, O., Fan, C., Livasy, C., Herschkowitz, J. I., et al. (2010). Breast Cancer Research, 12, R68.
Hennessy, B. T., Gonzalez-Angulo, A. M., Stemke-Hale, K., Gilcrease, M. Z., Krishnamurthy, S., Lee, J. S., et al. (2009). Cancer Research, 69, 4116–4124.
Moreno-Bueno, G., Portillo, F., & Cano, A. (2008). Oncogene, 27, 6958–6969.
Creighton, C. J., Chang, J. C., & Rosen, J. M. (2010). Journal of Mammary Gland Biology and Neoplasia, 15, 253–260.
Martinez-Estrada, O. M., Culleres, A., Soriano, F. X., Peinado, H., Bolos, V., Martinez, F. O., et al. (2006). The Biochemical Journal, 394, 449–457.
Acknowledgements
We are grateful to Dr. Jane Aubin for critical reading of this commentary and providing continuous intellectual support for our work. Our work on Claudins has been supported by CIHR.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Turksen, K. Claudins and Cancer Stem Cells. Stem Cell Rev and Rep 7, 797–798 (2011). https://doi.org/10.1007/s12015-011-9267-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-011-9267-1